Want to join the conversation?
Health insurance company $ANTM's 1Q16 operating revenue rose 7.7% versus 1Q15, mainly due to higher premium revenue in the Government Business segment and increased administrative fees and higher premium revenue in the Commercial and Specialty Business segment.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.